CFR section

21 CFR 600.12(a): Records

PART 600-BIOLOGICAL PRODUCTS: GENERAL · Subpart B-Establishment Standards

Key facts

Citation 21 CFR 600.12(a)
Section Records
Part PART 600-BIOLOGICAL PRODUCTS: GENERAL
Subpart Subpart B-Establishment Standards
Subchapter 21 CFR F Biologics
Product types cited Biologics, Devices, Drugs
Regulation text (excerpt) (a) Maintenance of records. Records shall be made, concurrently with the performance, of each step in the manufacture and distribution of products, in such a manner that at any time successive steps in the manufacture and distribution of any lot may be traced by an inspector. Such records shall be legible and indelible, shall identify the person immediately responsible, shall include dates of the various steps, and be as detailed as necessary for clear understanding of each step by one…

At a glance

  • 10–99 Inspections citing this section
  • 1–9 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA